businesspress24.com - IntelGenx to Report Third Quarter 2017 Financial Results on November 9, 2017 - Conference Call to Fo
 

IntelGenx to Report Third Quarter 2017 Financial Results on November 9, 2017 - Conference Call to Follow

ID: 1527127

(firmenpresse) - SAINT-LAURENT, QUEBEC -- (Marketwired) -- 11/02/17 -- IntelGenx Technologies Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that it will release its third quarter 2017 financial results after market close on November 9, 2017.

An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer, and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:

Webcast Registration:

Following the live call, a replay will be available on the Company''s website, , under "Investor Relations".

About IntelGenx:

Established in 2003, IntelGenx is a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform.

IntelGenx'' highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx'' state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to its clients. More information about the company can be found at .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange), nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Source: IntelGenx Technologies Corp.



Contacts:
IntelGenx Technologies Corp.
Stephen Kilmer
Investor Relations
(514) 331-7440 ext 232


IntelGenx Technologies Corp.
Andre Godin, CPA, CA
Executive Vice-President and CFO
(514) 331-7440 ext 203




Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Tauriga Sciences, Inc. Confirms Canadian Trading Halt Lifted at Open of Market on November 1, 2017
Nephros Announces Approval of $1.9 Million in NJEDA NOL Program Tax Credits
Bereitgestellt von Benutzer: Marketwired
Datum: 02.11.2017 - 15:30 Uhr
Sprache: Deutsch
News-ID 1527127
Anzahl Zeichen: 3174

contact information:
Contact person:
Town:

SAINT-LAURENT, QUEBEC


Phone:

Kategorie:

Health & Nutrition


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 1173 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"IntelGenx to Report Third Quarter 2017 Financial Results on November 9, 2017 - Conference Call to Follow
"
steht unter der journalistisch-redaktionellen Verantwortung von

IntelGenx Technologies Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von IntelGenx Technologies Corp.



 

Who is online

All members: 10 561
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 70


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.